Pune-based agri biotech startup, BioPrime Agrisolutions (BioPrime), has raised $6 million in a Series A funding round led by Belgium-based Edaphon, marking the firm’s first investment in Asia. Existing investors Omnivore and Inflexor also participated equally in this round, signaling continued confidence in BioPrime’s vision.
BioPrime previously secured Rs 9 crore in a pre-Series A round in October 2022, also backed by Inflexor Ventures and Omnivore. The startup has garnered support from several prominent institutions, including BIRAC, DBT (Govt. of India), Venture Center, NCL Biotech Business Incubator, RICH, Telangana Government, and UnLtd India.
The fresh funding will enable BioPrime to accelerate research and development in the crop protection space. The company plans to co-develop novel biofungicides and bioinsecticides, expanding its existing product portfolio. Founded by Renuka Karandikar, Amit Shinde, and Shekhar Bhosle, BioPrime focuses on creating affordable agribiologicals that enhance crops’ physiological responses through small biomolecules. These products not only boost crop resistance to pests but also improve resilience to environmental stressors such as drought, excessive water, and extreme temperatures.
BioPrime is now setting its sights on international expansion. The company plans to launch its innovative biostimulant products in key markets such as North America, Brazil, and Southeast Asia. Trials are already underway in the U.S. for this purpose.
At the core of BioPrime’s innovation is its proprietary BioNexus platform, which has identified over 170 novel microbial strains from its extensive library of 18,000 strains. This technology will be instrumental in advancing and accelerating the development of new products as the company continues to scale globally.
